Parkinson’s Disease / 2014 / Article / Tab 2

Clinical Study

Parkinson’s Disease: Low-Dose Haloperidol Increases Dopamine Receptor Sensitivity and Clinical Response

Table 2

SCOPA ratings at the end of each week.

CaseWeek 1Week 2Week 3Week 4Week 5Week 6Week 7

10114111015121714
10225292025282219
10342464948524947
10426293232333433
10523202222252823
10629252728302733
10720181717111515
10827201617121510
10916141417161513
11016101512121412
11230182124191916
11321161720192621
11428202117202023
11530273028302928
11713997778
11817201813141823

Av.23.618.9221.121.321.322.221.1
S.E.1.92.32.42.42.92.52.6

Data for subgroup analysis:
Av.20.817.116.717.116.251816.4
S.E.1.71.61.21.51.81.61.5
0.0070.00080.0040.0070.0580.016

values, using matched, one tail students -test).
Four severe cases (and nonresponders; 104, 106, 103, and 115) were removed for the subgroup analysis.

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.